11/09/2025
Cup of coffee a day may not be harmful for some adults with AFib and could lower episodes
American Heart Association Scientific Sessions 2025
NEW ORLEANS, Nov. 9, 2025 — Adults treated for atrial fibrillation (AFib) who drank a daily cup of coffee were 39% less likely to have an irregular heart rhythm episode compared to those who avoided all caffeinated products, according to a new study. The preliminary late-breaking science was presented today at the American Heart Association’s Scientific Sessions 2025. The meeting, Nov. 7-10, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.
“We conducted this study to assess whether caffeinated coffee increased or decreased the risk of AFib. Participants were randomly assigned to continue drinking at least one cup of caffeinated coffee daily or to avoid any caffeine for 6 months,” said study lead author Christopher X. Wong, M.B.B.S., M.Sc., M.P.H., Ph.D., formerly of the University of California, San Francisco, and currently professor of cardiology at the University of Adelaide in Australia.
The Does Eliminating Coffee Avoid Fibrillation (DECAF) trial enrolled 200 adults diagnosed with AFib who experienced an irregular, fast heart rhythm and were about to be treated with cardioversion therapy, using medication or an electrical shock to restore a normal rhythm. Participants reported that they typically drank about one cup of caffeinated coffee per day, and they agreed to follow the researchers’ advice on caffeine for 6 months after the cardioversion therapy. Half of the participants were randomly chosen to continue drinking at least one cup of coffee daily, and the other half were instructed to avoid all caffeine.
During the 6-month study:
The coffee group maintained their pre-enrollment habit of drinking about 1 cup of coffee a day, while the no coffee group reported that they consumed no caffeine each day.
47% of the participants in the coffee group had a recurrent AFib or atrial flutter (rapid but regular heartbeat) episode lasting more than 30 seconds, compared with 64% of the no-caffeine group, representing a 39% lower risk among the coffee drinkers.
Similar reductions in risk were found when only AFib episodes (excluding atrial flutter episodes) were considered.
“Our study results suggest that caffeinated coffee may not be responsible for raising the risk of AFib and may even reduce it,” said senior study author Gregory M. Marcus, M.D., M.A.S., a professor of medicine at the University of California, San Francisco.
This study enrolled only people who already drink coffee, so future studies might investigate whether AFib episodes are reduced in people who start drinking coffee or other caffeinated beverages for the first time.
Because the study participants consumed about one cup of coffee per day, the results may not apply to people who drink more coffee or other beverages containing caffeine, such as energy drinks.
“It is reasonable for health care professionals to let their AFib patients consider experimenting with naturally caffeinated substances that they may enjoy, such as caffeinated tea and coffee. However, some people may still find that caffeine or caffeinated coffee triggers or worsens their AFib,” Marcus said.
AFib currently affects more than 6 million people in the U.S. and can lead to blood clots, stroke, heart failure and other heart-related conditions, according to the American Heart Association’s 2025 Heart Disease and Stroke Statistics.❤️💝
